Manimaran Vasanthan

1.2k total citations · 1 hit paper
24 papers, 704 citations indexed

About

Manimaran Vasanthan is a scholar working on Pharmaceutical Science, Analytical Chemistry and Biomaterials. According to data from OpenAlex, Manimaran Vasanthan has authored 24 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmaceutical Science, 4 papers in Analytical Chemistry and 3 papers in Biomaterials. Recurrent topics in Manimaran Vasanthan's work include Drug Solubulity and Delivery Systems (5 papers), Analytical Methods in Pharmaceuticals (4 papers) and Advancements in Transdermal Drug Delivery (3 papers). Manimaran Vasanthan is often cited by papers focused on Drug Solubulity and Delivery Systems (5 papers), Analytical Methods in Pharmaceuticals (4 papers) and Advancements in Transdermal Drug Delivery (3 papers). Manimaran Vasanthan collaborates with scholars based in India, Malaysia and Vietnam. Manimaran Vasanthan's co-authors include J. Narayanan, Roxana Yolanda Castillo-Acobo, Matin Chehelgerdi, Omer Qutaiba B. Allela, Mabrouk A. Abo‐Zaid, L. Natrayan, Mohamed J. Saadh, Tamilanban Thamaraikani, Devendra Pratap Rao and Mohammad Chehelgerdi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Molecular Cancer.

In The Last Decade

Manimaran Vasanthan

18 papers receiving 686 citations

Hit Papers

Progressing nanotechnolog... 2023 2026 2024 2023 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manimaran Vasanthan India 7 252 250 226 117 89 24 704
J. Narayanan India 7 259 1.0× 275 1.1× 246 1.1× 119 1.0× 91 1.0× 22 803
Ahmed Ismail Saudi Arabia 7 232 0.9× 211 0.8× 227 1.0× 112 1.0× 91 1.0× 21 772
Tamilanban Thamaraikani India 6 227 0.9× 205 0.8× 226 1.0× 104 0.9× 90 1.0× 17 625
Mabrouk A. Abo‐Zaid Saudi Arabia 3 225 0.9× 204 0.8× 201 0.9× 104 0.9× 83 0.9× 6 562
Robin Kumar India 13 232 0.9× 215 0.9× 307 1.4× 147 1.3× 57 0.6× 46 793
Mohamed J. Saadh Jordan 4 224 0.9× 204 0.8× 208 0.9× 103 0.9× 83 0.9× 17 574
Naresh Mittapelly India 16 194 0.8× 226 0.9× 234 1.0× 73 0.6× 95 1.1× 23 687
Gigi N.C. Chiu Singapore 15 177 0.7× 275 1.1× 428 1.9× 70 0.6× 93 1.0× 19 916
Beatriz García-Pinel Spain 9 201 0.8× 244 1.0× 228 1.0× 54 0.5× 58 0.7× 10 549
Devendra Pratap Rao India 8 228 0.9× 207 0.8× 217 1.0× 146 1.2× 158 1.8× 54 747

Countries citing papers authored by Manimaran Vasanthan

Since Specialization
Citations

This map shows the geographic impact of Manimaran Vasanthan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manimaran Vasanthan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manimaran Vasanthan more than expected).

Fields of papers citing papers by Manimaran Vasanthan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manimaran Vasanthan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manimaran Vasanthan. The network helps show where Manimaran Vasanthan may publish in the future.

Co-authorship network of co-authors of Manimaran Vasanthan

This figure shows the co-authorship network connecting the top 25 collaborators of Manimaran Vasanthan. A scholar is included among the top collaborators of Manimaran Vasanthan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manimaran Vasanthan. Manimaran Vasanthan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tamilanban, T., et al.. (2025). Safety assessment of resveratrol surrogate molecule 5 (RSM5): Acute and sub-acute oral toxicity studies in BALB/c mice. Toxicology Reports. 14. 101956–101956. 1 indexed citations
4.
Ahmad, Ahmad Y. A. Bani, et al.. (2025). Efficient hybrid heuristic adopted deep learning framework for diagnosing breast cancer using thermography images. Scientific Reports. 15(1). 13605–13605. 3 indexed citations
6.
Kannaiah, Kanaka Parvathi, et al.. (2024). Enhancing Pharmaceutical Product Quality With a Comprehensive Corrective and Preventive Actions (CAPA) Framework: From Reactive to Proactive. Cureus. 16(9). e69762–e69762. 1 indexed citations
7.
Srinivasan, T. M., Tamilanban Thamaraikani, Vetriselvan Subramaniyan, et al.. (2024). Reviewing the literature of 3D printing of bones and cartilage: Evidence and practice. SHILAP Revista de lepidopterología. 16. 100180–100180.
8.
Vasanthan, Manimaran, et al.. (2024). A Review of Safety, Quality, Regulation, and Delivery Approaches for Phytopharmaceuticals. Jordan Journal of Pharmaceutical Sciences. 17(2). 316–332. 5 indexed citations
9.
Vasanthan, Manimaran, et al.. (2024). A Comprehensive Review on Solid Lipid Nanoparticles as a Carrier for Oral Absorption of Phyto-Bioactives. Cureus. 16(8). e68339–e68339. 1 indexed citations
10.
Prasanna, B. M., et al.. (2024). The Role of Quality Assurance in Clinical Trials: Safeguarding Data Integrity and Compliance. Cureus. 16(8). e67573–e67573. 1 indexed citations
11.
Chehelgerdi, Mohammad, Matin Chehelgerdi, Omer Qutaiba B. Allela, et al.. (2023). Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Molecular Cancer. 22(1). 169–169. 552 indexed citations breakdown →
12.
Vasanthan, Manimaran, T. Tamilanban, J. Narayanan, et al.. (2023). Nanogels as novel drug nanocarriers for CNS drug delivery. Frontiers in Molecular Biosciences. 10. 1232109–1232109. 68 indexed citations
13.
Vasanthan, Manimaran, et al.. (2020). Nanoemulsions: A Better Approach for Antidiabetic Drug Delivery. Current Diabetes Reviews. 17(4). 486–495. 3 indexed citations
14.
Vasanthan, Manimaran & Damodharan Narayanasamy. (2017). DEVELOPMENT OF FAST-DISSOLVING TABLETS OF AMLODIPINE BESYLATE BY SOLID DISPERSION TECHNOLOGY USING POLOXAMER 407 AND POLOXAMER 188. Asian Journal of Pharmaceutical and Clinical Research. 10(7). 135–135. 10 indexed citations
15.
Vasanthan, Manimaran & Damodharan Narayanasamy. (2016). Development of Fast Dissolving Tablets of Nisoldipine by Solid Dispersion Technology using Poloxamer 407 and Poloxamer 188. Journal of Young Pharmacists. 8(4). 341–349. 10 indexed citations
16.
Vasanthan, Manimaran, et al.. (2016). Study on Strength Characteristics of Soil with Agro Waste. Indian Journal of Science and Technology. 9(33). 1 indexed citations
17.
Vasanthan, Manimaran, et al.. (2014). FORMULATION AND EVALUATION OF NAPROXEN-EUDRAGIT® RS 100 NANOSUSPENSION USING 32 FACTORIAL DESIGN. International Journal of Pharmacy and Pharmaceutical Sciences. 6(7). 449–455. 2 indexed citations
18.
Vasanthan, Manimaran, et al.. (2014). Development of Low Carbon Aquaculture System by Using Zeolite. 4(5). 295–310. 1 indexed citations
19.
Vasanthan, Manimaran, et al.. (2012). Formulation and evaluation of Rizatriptan Benzoate OrallyDisintegrating Tablets. International Journal of Drug Development and Research. 4(2). 1 indexed citations
20.
Vasanthan, Manimaran, et al.. (2010). ENHANCEMENT OF DISSOLUTION RATE OF GLIBENCLAMIDE BY SOLID DISPERSION TECHNOLOGY. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026